ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GAP Pharmagap Inc.

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Pharmagap Inc. TSXV:GAP TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

TSX Venture Exchange Cease Trade Order

06/05/2013 7:47pm

PR Newswire (Canada)


Pharmagap Inc. (TSXV:GAP)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Pharmagap Inc. Charts.

VANCOUVER, May 6, 2013 /CNW/ -

BULLETIN TYPE:  Cease Trade Orders
BULLETIN DATE:  May 6, 2013
TSX Venture Companies

A Temporary Cease Trade Orders has been issued by the Ontario Securities Commission on May 6, 2013 against the following companies for failing to file the documents indicated within the required time period:

Symbol  Tier  Company  Failure to File  Period
        Ending
        (Y/M/D)
ACX  Acadian Energy Inc.  Audited annual financial statements  
      for the year ended  12/12/31
         
      Management's discussion and analysis  
      relating to the audited annual financial  
      statements for the year ended  12/12/31
         
      Certification of the foregoing filings as  
      required by National Instrument 52-109  
      Certification of Disclosure in Issuers'  
      Annual and Interim Filings.  
         
GAP  PharmaGap Inc.  Audited annual financial statements  
      for the year ended  12/12/31
         
      Management's discussion and analysis  
      relating to the audited annual financial  
      statements for the year ended  12/12/31
         
      Certification of the foregoing filings as  
      required by National Instrument 52-109  
      Certification of Disclosure in Issuers'  
      Annual and Interim Filings.  
         
ICL  Intellectual Capital Group Ltd.  Audited annual financial statements  
      for the year ended  12/12/31
         
      Management's discussion and analysis  
      relating to the audited annual financial  
      statements for the year ended  12/12/31
         
      Certification of the foregoing filings as  
      required by National Instrument 52-109  
      Certification of Disclosure in Issuers'  
      Annual and Interim Filings.  
         
MDX  MedX Health Corp.  Audited annual financial statements  
      for the year ended  12/12/31
         
      Management's discussion and analysis  
      relating to the audited annual financial  
      statements for the year ended  12/12/31
         
      Certification of the foregoing filings as  
      required by National Instrument 52-109  
      Certification of Disclosure in Issuers'  
      Annual and Interim Filings.  
         

Upon revocation of the Temporary Cease Trade Orders, the companies' shares will remain suspended until the companies meet TSX Venture Exchange requirements.  Members are prohibited from trading in the securities of the companies during the period of the suspension or until further notice.

________________________________________

 

 

SOURCE TSX Venture Exchange

Copyright 2013 Canada NewsWire

1 Year Pharmagap Inc. Chart

1 Year Pharmagap Inc. Chart

1 Month Pharmagap Inc. Chart

1 Month Pharmagap Inc. Chart

Your Recent History

Delayed Upgrade Clock